Shanghai, China

Kevin Kun-Chin Liu

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Pfizer Corporation, Pfizer Products Inc., Eli Lilly and Company. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Kun-Chin Liu. Retrieved from https://idiyas.com/inventor/kevin-kun-chin-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 25.0


 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 13(Granted Patents)


Location History:

  • San Marcos, CA (US) (2012 - 2015)
  • Shanghai, CN (2015 - 2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kevin Kun-Chin Liu: Innovator in Pharmaceutical Compounds

Introduction

Kevin Kun-Chin Liu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of four patents to his name, Liu's work has garnered attention in the scientific community.

Latest Patents

Among his latest patents, Liu has developed fluorophenyl pyrazol compounds. This invention provides a compound of a specific formula, where various groups are selected from defined categories. Additionally, he has worked on pyrrolopyrimidine and purine derivatives, which relate to compounds of a particular formula that hold potential pharmaceutical applications.

Career Highlights

Liu has had a distinguished career, having worked with prominent companies such as Pfizer Corporation and Pfizer Products Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Throughout his career, Liu has collaborated with talented individuals, including Iriny Botrous and Yufeng Hong. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kevin Kun-Chin Liu stands out as an influential inventor in the pharmaceutical industry. His innovative compounds and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…